| A Clinical Study of FT1 in Patients With Short Bowel Syndrome (NCT07704047) | Chongqing Peg-Bio Biopharm Co., Ltd. | 2026-08-30 |
| A Clinical Study of PA5 in Patients With Advanced Solid Tumors (NCT07702162) | Chongqing Peg-Bio Biopharm Co., Ltd. | 2025-11-14 |
| A Clinical Study on the Safety and Tolerability of PL54 Injection in Adult Patients With Phenylketonuria (PKU) (NCT07672756) | Chongqing Peg-Bio Biopharm Co., Ltd. | 2025-07-20 |
| A Study to Evaluate the Safety and Efficacy of PN20 in the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure (NCT07446491) | Chongqing Peg-Bio Biopharm Co., Ltd. | 2025-06-06 |
| Study of PN20 in Adult Patients With Primary Immune Thrombocytopenia (ITP) (NCT06880081) | Chongqing Peg-Bio Biopharm Co., Ltd. | 2025-03-07 |
| Efficacy and Safety of PJ009 in Patients With Short Bowel Syndrome Requiring Parenteral Nutrition (NCT06512584) | Chongqing Peg-Bio Biopharm Co., Ltd. | 2024-09-03 |
| A Study of FT1 in Healthy Adult Volunteers (NCT06610487) | Chongqing Peg-Bio Biopharm Co., Ltd. | 2024-08-20 |
| A Study of PN20 for the Prevention of Chemotherapy-induced Thrombocytopenia in Lymphoma or Solid Tumor Patients (NCT06521931) | Chongqing Peg-Bio Biopharm Co., Ltd. | 2023-12-06 |
| A Study of PD5K3 in Healthy Adult Volunteers (NCT06527781) | Chongqing Peg-Bio Biopharm Co., Ltd. | 2023-11-27 |
| A Study of PJ009 in Healthy Adult Volunteers (NCT06523101) | Chongqing Peg-Bio Biopharm Co., Ltd. | 2023-02-28 |
| A Study of PN20 in Healthy Adult Volunteers (NCT06523088) | Chongqing Peg-Bio Biopharm Co., Ltd. | 2022-06-16 |